Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

August 30, 2024

Conditions
Non-healing WoundDiabetic Foot Ulcer
Interventions
DEVICE

AC5® Advanced Wound System

This group will receive AC5® Advanced Wound system, a synthetic self-assembling peptide matrix to the wound and covered with non-adherent dressing followed with appropriate outer dressing to maintain moisture balance. AC5 is applied weekly and outer dressing will be redressed as necessary.

DEVICE

Fibracol Plus Collagen Dressing

This group will receive Fibracol Plus collagen dressing to the wound and covered with appropriate out dressing. Treatment will be done 3x a week.

Trial Locations (2)

27834

NOT_YET_RECRUITING

Dr. Christopher Gauland, Greenville

44113

RECRUITING

Dr. Brock Liden, Circleville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Arch Therapeutics

INDUSTRY

NCT06028386 - Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter